Efficacy and Safety of Oblique Lumbar Interbody Fusion Versus Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spondylolisthesis: A Systematic Review and Meta-Analysis
- PMID: 34871803
- DOI: 10.1016/j.wneu.2021.11.127
Efficacy and Safety of Oblique Lumbar Interbody Fusion Versus Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spondylolisthesis: A Systematic Review and Meta-Analysis
Abstract
Objective: We critically evaluated the efficacy and safety of oblique lumbar interbody fusion (OLIF) versus transforaminal lumbar interbody fusion (TLIF) for degenerative lumbar spondylolisthesis (DLS).
Methods: PubMed, Embase, Cochrane Library, the Web of Science Core Collection, Chinese Biomedical Literature, China National Knowledge Infrastructure, Wanfang Digital Periodicals, and Chinese Science and Technology Periodicals were searched from their inception to February 2021. Randomized controlled trials and retrospective or prospective cohort studies (CSs) comparing OLIF and TLIF for DLS were included. A meta-analysis was conducted, if possible.
Results: Ten studies were included in the statistical analysis. The pooled results of the CSs showed no statistically significant differences (P > 0.05) in pain relief at 3 or 6 months of follow-up and functional improvement at 1 or 3 months of follow-up in DLS patients between those who had undergone OLIF versus TLIF. The pooled results of the CSs showed that OLIF could significantly improve the degree of lumbar lordosis, foraminal height, and disc height and decrease the intraoperative blood loss, postoperative drainage volume, operative duration, bed rest time, and hospital length of stay (P < 0.05) compared with TLIF. The incidence of adverse events was not significantly different statistically between OLIF and TLIF.
Conclusions: The results from the present study suggest that pain relief and functional improvement were not significantly different between OLIF and TLIF. Nevertheless, the use of OLIF might improve radiological outcomes and reduce intraoperative blood loss, postoperative drainage volume, operative duration, bed rest duration, and hospital length of stay compared with TLIF. Additional high-quality randomized controlled trials are still required to confirm these findings.
Keywords: Degenerative lumbar spondylolisthesis; Lumbar interbody fusion; Meta-analysis; Systematic review.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
[Clinical and radiologic comparison between oblique lateral interbody fusion and minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis].Zhongguo Gu Shang. 2023 May 25;36(5):414-9. doi: 10.12200/j.issn.1003-0034.2023.05.004. Zhongguo Gu Shang. 2023. PMID: 37211931 Chinese.
-
Meta-analysis of minimally invasive transforaminal lumbar interbody fusion versus oblique lumbar interbody fusion for treating lumbar degenerative diseases.J Orthop Surg Res. 2024 Dec 30;19(1):891. doi: 10.1186/s13018-024-05422-3. J Orthop Surg Res. 2024. PMID: 39736715 Free PMC article.
-
Comparison of Outcomes between Robot-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion and Oblique Lumbar Interbody Fusion in Single-Level Lumbar Spondylolisthesis.Orthop Surg. 2021 Oct;13(7):2093-2101. doi: 10.1111/os.13151. Epub 2021 Oct 1. Orthop Surg. 2021. PMID: 34596342 Free PMC article.
-
Meta-analysis of the efficacy and safety of OLIF and TLIF in the treatment of degenerative lumbar spondylolisthesis.J Orthop Surg Res. 2024 Apr 15;19(1):242. doi: 10.1186/s13018-024-04703-1. J Orthop Surg Res. 2024. PMID: 38622724 Free PMC article.
-
Short-term and mid-term evaluation of three types of minimally invasive lumbar fusion surgery for treatment of L4/L5 degenerative spondylolisthesis.Sci Rep. 2024 Feb 21;14(1):4320. doi: 10.1038/s41598-024-54970-5. Sci Rep. 2024. PMID: 38383595 Free PMC article.
Cited by
-
Efficacy of oblique lumbar interbody fusion versus transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a systematic review and meta-analysis.Arch Orthop Trauma Surg. 2023 Sep;143(9):5657-5670. doi: 10.1007/s00402-023-04880-4. Epub 2023 Apr 20. Arch Orthop Trauma Surg. 2023. PMID: 37079105 Free PMC article.
-
Beneficial influence of single-stage posterior surgery for the treatment of lumbar brucella spondylitis combined with spondylolisthesis.Sci Rep. 2022 Nov 14;12(1):19459. doi: 10.1038/s41598-022-24223-4. Sci Rep. 2022. PMID: 36376442 Free PMC article.
-
Comparisons of oblique lumbar interbody fusion and transforaminal lumbar interbody fusion for degenerative spondylolisthesis: a prospective cohort study with a 2-year follow-up.Front Surg. 2023 Apr 27;10:1115823. doi: 10.3389/fsurg.2023.1115823. eCollection 2023. Front Surg. 2023. PMID: 37181603 Free PMC article.
-
Hidden Blood Loss and Its Risk Factors for Oblique Lumbar Interbody Fusion.J Clin Med. 2024 Mar 2;13(5):1454. doi: 10.3390/jcm13051454. J Clin Med. 2024. PMID: 38592273 Free PMC article.
-
Preoperative CT attenuation value classification assesses cage subsidence risk in 112 OLIF surgery cases.Sci Rep. 2025 Mar 25;15(1):10276. doi: 10.1038/s41598-025-94696-6. Sci Rep. 2025. PMID: 40133602 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources